Original Research
Published on 24 Mar 2025
The serum proteomic profile in patients with migraine
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1460403
Type at least 3 characters
1,045 articles
Articles
Original Research
Published on 21 Mar 2025
Soy-based purified ingredient diet affects mouse gut permeability and the microbiome in fragile X mice
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1520211
- 175 views
Original Research
Accepted on 19 Mar 2025
Brain microvascular endothelial cells differentiated from a Friedreich's Ataxia patient iPSC are deficient in tight junction protein expression and paracellularly permeable
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1511388
Mini Review
Published on 19 Mar 2025
Elevated propionate and its association with neurological dysfunctions in propionic acidemia
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1499376
- 148 views
Review
Accepted on 14 Mar 2025
NFE2L1 as a Central Regulator of Proteostasis in Neurodegenerative Diseases: Interplay with Autophagy, Ferroptosis, and the Proteasome
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1551571
Mini Review
Accepted on 10 Mar 2025
Neurotrophic Factor Alpha 1 Gene Therapy in Alzheimer's Disease: Scope and advancements
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1518868
- 141 views
Original Research
Published on 04 Mar 2025
Bioenergetic-related gene expression in the hippocampus predicts internalizing vs. externalizing behavior in an animal model of temperament
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1469467
- 656 views
Original Research
Published on 20 Feb 2025
Multi-omics-based phenotyping of AFG3L2-mutant lymphoblasts determines key factors of a pathophysiological interplay between mitochondrial vulnerability and neurodegeneration in spastic ataxia type 5
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1548255
- 641 views
Original Research
Published on 19 Feb 2025
Impaired cerebrospinal fluid circulation and cerebral lymphatic drainage in a rat model of chronic hydrocephalus
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1516265
- 718 views
Opinion
Published on 18 Feb 2025
Histone monoaminylation is a novel epigenetic mechanism in psychiatric disorders
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1534569
- 664 views
Original Research
Published on 13 Feb 2025
Deciphering motor dysfunction and microglial activation in mThy1-α-synuclein mice: a comprehensive study of behavioral, gene expression, and methylation changes
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1544971
- 547 views
Review
Published on 11 Feb 2025
The emerging role of glycine receptor α2 subunit defects in neurodevelopmental disorders
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1550863
- 991 views
Original Research
Published on 05 Feb 2025
The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1524044
- 750 views
Original Research
Published on 05 Feb 2025
Ectopic expression of the cation-chloride cotransporter KCC2 in blood exosomes as a biomarker for functional rehabilitation
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1522571
- 703 views
Original Research
Published on 29 Jan 2025
Short- and long-term changes in neurological, behavioural, and blood biomarkers following repeated mild traumatic brain injury in rats—potential biological sex-dependent effects
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1488261
- 998 views
Review
Published on 27 Jan 2025
Regulatory mechanism of Reelin activity: a platform for exploiting Reelin as a therapeutic agent
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2025.1546083
- 1,049 views